ReviewCNS drugs2026

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.

Susan Abushakra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.